50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,655.04
DOW   29,260.81
QQQ   274.37
This Device Makes Creating Voice Memos Easy
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
Three Consumer Stocks That Could Outperform In Q4 
Will Synthetic Biology Firm Amyris Post Net Income In 2024?
The Safest Option in Trades! (Ad)pixel
Comcast is an Asset Bonanza Priced Cheap
US stocks slip deeper into a slump as recession fears grow
The Safest Option in Trades! (Ad)pixel
British pound plunges to new low as tax cuts spark concern
Lights out, ovens off: Europe preps for winter energy crisis
S&P 500   3,655.04
DOW   29,260.81
QQQ   274.37
This Device Makes Creating Voice Memos Easy
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
Three Consumer Stocks That Could Outperform In Q4 
Will Synthetic Biology Firm Amyris Post Net Income In 2024?
The Safest Option in Trades! (Ad)pixel
Comcast is an Asset Bonanza Priced Cheap
US stocks slip deeper into a slump as recession fears grow
The Safest Option in Trades! (Ad)pixel
British pound plunges to new low as tax cuts spark concern
Lights out, ovens off: Europe preps for winter energy crisis
S&P 500   3,655.04
DOW   29,260.81
QQQ   274.37
This Device Makes Creating Voice Memos Easy
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
Three Consumer Stocks That Could Outperform In Q4 
Will Synthetic Biology Firm Amyris Post Net Income In 2024?
The Safest Option in Trades! (Ad)pixel
Comcast is an Asset Bonanza Priced Cheap
US stocks slip deeper into a slump as recession fears grow
The Safest Option in Trades! (Ad)pixel
British pound plunges to new low as tax cuts spark concern
Lights out, ovens off: Europe preps for winter energy crisis
S&P 500   3,655.04
DOW   29,260.81
QQQ   274.37
This Device Makes Creating Voice Memos Easy
How To Earn a Tax-Advantaged 10% Dividend Yield (Ad)pixel
Three Consumer Stocks That Could Outperform In Q4 
Will Synthetic Biology Firm Amyris Post Net Income In 2024?
The Safest Option in Trades! (Ad)pixel
Comcast is an Asset Bonanza Priced Cheap
US stocks slip deeper into a slump as recession fears grow
The Safest Option in Trades! (Ad)pixel
British pound plunges to new low as tax cuts spark concern
Lights out, ovens off: Europe preps for winter energy crisis
NASDAQ:PBLA

Panbela Therapeutics - PBLA Short Interest Ratio & Short Volume

$0.34
+0.07 (+25.92%)
(As of 09/26/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.27
$0.53
50-Day Range
$0.24
$1.40
52-Week Range
$0.20
$2.40
Volume
5.74 million shs
Average Volume
212,063 shs
Market Capitalization
$7.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00

Panbela Therapeutics Short Interest Data

Current Short Volume
138,600 shares
Previous Short Volume
126,700 shares
Change Vs. Previous Month
+9.39%
Dollar Volume Sold Short
$95,744.88
Short Interest Ratio / Days to Cover
2.4
Last Record Date
August 31, 2022
Outstanding Shares
20,790,000 shares
Percentage of Shares Shorted
0.67%
Today's Trading Volume
5,736,564 shares
Average Trading Volume
212,063 shares
Today's Volume Vs. Average
2,605.12%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Panbela Therapeutics ?

Sign up to receive the latest short interest report for Panbela Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PBLA Short Interest Over Time

PBLA Days to Cover Over Time

PBLA Percentage of Float Shorted Over Time



Panbela Therapeutics (NASDAQ:PBLA) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/2022138,600 shares $95,744.88 +9.4%N/A2.4 $0.69
8/15/2022126,700 shares $150,773.00 -24.0%N/A2.7 $1.19
7/31/2022166,700 shares $206,708.00 -4.9%N/A3.7 $1.24
7/15/2022175,300 shares $194,583.00 +19.7%N/A3.9 $1.11
6/30/2022146,400 shares $96,638.64 -4.6%N/A3.1 $0.66
6/15/2022153,500 shares $193,410.00 +1.2%N/A4.4 $1.26
5/31/2022151,700 shares $227,550.00 +31.0%N/A8.6 $1.50
5/15/2022115,800 shares $185,534.76 -18.6%N/A4.1 $1.60
4/30/2022142,200 shares $251,694.00 -14.3%N/A4.3 $1.77
4/15/2022165,900 shares $328,482.00 +3.3%N/A4.5 $1.98
3/31/2022160,600 shares $338,866.00 +9.9%N/A4.3 $2.11
3/15/2022146,200 shares $248,540.00 -15.3%N/A3.2 $1.70
2/28/2022172,600 shares $336,570.00 +21.8%N/A3.3 $1.95
2/15/2022141,700 shares $317,408.00 -18.1%N/A2.4 $2.24
1/31/2022173,100 shares $368,703.00 -6.2%N/A3.1 $2.13
1/15/2022184,600 shares $304,590.00 -17.7%N/A3.3 $1.65
12/31/2021224,200 shares $387,888.42 +18.9%N/A4.1 $1.73
12/15/2021188,600 shares $330,050.00 -10.6%N/A3.7 $1.75
11/30/2021211,000 shares $390,350.00 +5.3%N/A4.1 $1.85
11/15/2021200,300 shares $426,639.00 -0.7%N/A3.5 $2.13
10/29/2021201,800 shares $431,852.00 -1.5%N/A3.6 $2.14
10/15/2021204,900 shares $405,702.00 +5.2%N/A1.6 $1.98
9/30/2021194,800 shares $422,716.00 -9.4%N/A1.3 $2.17
9/15/2021214,900 shares $472,780.00 -2.5%N/A0.9 $2.20
8/31/2021220,500 shares $500,535.00 -14.7%N/A0.9 $2.27
8/13/2021258,400 shares $607,240.00 +5.7%N/A1.1 $2.35
7/30/2021244,400 shares $615,888.00 +12.5%N/A1 $2.52
7/15/2021217,200 shares $562,548.00 -35.5%N/A1.3 $2.59
6/30/2021336,500 shares $952,295.00 +85.2%N/A2.1 $2.83
6/15/2021181,700 shares $675,924.00 -6.2%2.2%2.7 $3.72
5/28/2021193,800 shares $813,960.00 +6.9%2.3%3 $4.20
5/14/2021181,300 shares $692,566.00 -14.0%2.2%3.2 $3.82
4/30/2021210,900 shares $982,794.00 +18.2%2.5%1.8 $4.66
4/15/2021178,400 shares $713,600.00 -5.2%2.1%1.1 $4.00
3/31/2021188,100 shares $769,329.00 -3.9%2.3%1.2 $4.09
3/15/2021195,700 shares $884,564.00 +16.6%2.4%1.2 $4.52
2/26/2021167,800 shares $739,998.00 -12.2%2.2%0.8 $4.41
2/12/2021191,000 shares $1.03 million +38.3%2.5%1 $5.38
1/29/2021138,100 shares $760,240.50 +78.9%1.8%0.9 $5.51
1/15/202177,200 shares $633,040.00 No Change1.0%0.8 $8.20













PBLA Short Interest - Frequently Asked Questions

What is Panbela Therapeutics' current short interest?

Short interest is the volume of Panbela Therapeutics shares that have been sold short but have not yet been closed out or covered. As of August 31st, traders have sold 138,600 shares of PBLA short. Learn More on Panbela Therapeutics' current short interest.

What is a good short interest ratio for Panbela Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PBLA shares currently have a short interest ratio of 2.0. Learn More on Panbela Therapeutics's short interest ratio.

Is Panbela Therapeutics' short interest increasing or decreasing?

Panbela Therapeutics saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 138,600 shares, an increase of 9.4% from the previous total of 126,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Panbela Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Panbela Therapeutics: Tenax Therapeutics, Inc. (5.68%), Altamira Therapeutics Ltd. (3.52%), Avenue Therapeutics, Inc. (1.33%), InMed Pharmaceuticals Inc. (0.11%), Sonnet BioTherapeutics Holdings, Inc. (8.41%), Dermata Therapeutics, Inc. (1.56%), Aditxt, Inc. (180.86%), Statera Biopharma, Inc. (2.73%), Kiora Pharmaceuticals, Inc. (45.56%), and Histogen Inc. (4.48%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($4.91 billion), Charter Communications, Inc. ($3.53 billion), Suncor Energy Inc. ($2.26 billion), T. Rowe Price Group, Inc. ($2.01 billion), Chesapeake Energy Co. ($1.92 billion), Lucid Group, Inc. ($1.84 billion), Plug Power Inc. ($1.81 billion), Williams-Sonoma, Inc. ($1.66 billion), Coinbase Global, Inc. ($1.64 billion), and Lumen Technologies, Inc. ($1.50 billion). View all of the most shorted stocks.

What does it mean to sell short Panbela Therapeutics stock?

Short selling PBLA is an investing strategy that aims to generate trading profit from Panbela Therapeutics as its price is falling. PBLA shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Panbela Therapeutics?

A short squeeze for Panbela Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PBLA, which in turn drives the price of the stock up even further.

How often is Panbela Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PBLA, twice per month. The most recent reporting period available is August, 31 2022.



This page (NASDAQ:PBLA) was last updated on 9/27/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.